ENSC
Conviction 73HealthcareScan · Fri, Oct 9, 2026Ensysce Biosciences, Inc. (ENSC) closed at $0.5270 (+15.07%) on Oct 9, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 69, RS Rating 78, -79.8% from its 52-week high, -44.7% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
Financials as of Thu, Sep 30, 2021 · quarterly.
Congress activity
Disclosed STOCK Act trades in ENSC
Insider activity
SEC Form 4 transactions in ENSC · open-market 2 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
GOWER BOB G Director · Common Stock · 2026-08-07 | Buy | 400K | $198K | 2026-08-07 | 2026-08-18 |
GOWER BOB G Director · Warrant · 2026-04-23 | Convert | 254.31K | — | 2026-04-23 | 2026-08-18 |
GOWER BOB G Director · Common Stock · 2026-04-23 | Buy | 508.61K | $246K | 2026-04-23 | 2026-08-18 |
SEC filings
EDGAR filings in ENSC · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.